Doximity officer proposes $84K sale of 2,523 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Doximity, Inc. (DOCS) officer Siddharth Sitaram reported a proposed sale of 2,523 common shares, with an aggregate market value of $84,041.13 and an approximate sale date of November 16, 2026. The shares are listed as acquired from the issuer through a stock option exercise, with cash payment, on that date.
The notice lists February 27, 2026 as the date of plan adoption or instruction if relying on Rule 10b5-1. It also reports Sitaram’s earlier sales of 2,613 shares for gross proceeds of $80,166.84 on October 14, 2026, and 2,077 shares for $54,043.54 on September 15, 2026.
Key Figures
Key Terms
Stock Option Exercise financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does Siddharth Sitaram’s DOCS notice list a Rule 10b5-1 date?
AI-generated analysis. How Rhea-AI works. Not financial advice.